Gauti Kjartan Gíslason

10PUBLICATIONS
23CO-AUTHORS
Immunogenetics (incl. genetic immunology)Medical mycologyMedical molecular engineering of nucleic acids and proteinsHaematologyMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 11, 2026
Impact of SARS-CoV-2 vaccination on monoclonal gammopathy of undetermined significance: results from the population-based iStopMM study.

Robert Palmason, Elias Eythorsson, Sæmundur Rögnvaldsson

|May 20, 2024
Association Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance : An Analysis From a Population-Based Screening Study.

Ingigerdur Sverrisdottir, Sigrun Thorsteinsdottir, Sæmundur Rognvaldsson

|Apr 01, 2024
Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined Significance : A Cohort Study Nested in a Clinical Trial.

Elias Eythorsson, Saemundur Rognvaldsson, Sigrun Thorsteinsdottir

|Dec 01, 2023
Determining hemodilution in diagnostic bone marrow aspirated samples in plasma cell disorders by next-generation flow cytometry: Proposal for a bone marrow quality index.

Jón Þórir Óskarsson, Sæmundur Rögnvaldsson, Sigrun Thorsteinsdottir

|Mar 21, 2023
Author Correction: Prevalence of smoldering multiple myeloma based on nationwide screening.

Sigrún Thorsteinsdóttir, Gauti K Gíslason, Thor Aspelund

|Mar 20, 2023
Correction: Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies.

Sæmundur Rögnvaldsson, Thorvardur Jon Love, Sigrun Thorsteinsdottir

Pageof 2

Frequent Collaborators

11 joint publications

Sigrun Thorsteinsdottir

9 joint publications

Ola Landgren

8 joint publications

Sæmundur Rognvaldsson

8 joint publications

Sigurdur Yngvi Kristinsson